Search Articles
Discover groundbreaking research in biomedical sciences
Protocol for Systematic Review and Meta-Analysis of Pharmacological Interventions in MAFLD: GLP-1 Receptor Agonists as an Exemplar
Metabolic-associated fatty liver disease (MAFLD) affects approximately 25% of the global population, yet pharmacological treatment options remain limited despite potentially severe complications. Mul…
Minireview on CB1 Receptor Allosteric Modulation
The endocannabinoid system (ECS) constitutes a multifaceted neuromodulatory network orchestrating a spectrum of physiological processes through the interplay of endogenous ligands, metabolic enzymes,…
Systems-Level Identification Of Metabolic Dysfunction-Associated Steatotic Liver Disease Targets: A Bioinformatics Approach
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD, affects about 30% of adults worldwide and remains without effective pharmacotherapy. Its complex pathogenesi…
Nature's Arsenal Against NAFLD: Computational Analysis of Bioactive Plant Compounds
Non-alcoholic fatty liver disease (NAFLD) presents a significant global health challenge. This study investigates the therapeutic potential of plant-derived compounds in NAFLD treatment using advance…